Integrin α10β1-selected mesenchymal stem cells reduced hypercoagulopathy in a porcine model of acute respiratory distress syndrome

Integrin α10β1-selected mesenchymal stem cells reduced hypercoagulopathy in a porcine model of acute respiratory distress syndrome

Abstract Mesenchymal stem cells (MSCs) have been studied for their potential benefits in treating acute respiratory distress syndrome (ARDS) and have reported mild effects when trialed within human clinical trials. MSCs have been investigated in preclinical models with efficacy when administered at...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Dag Edström, Anna Niroomand, Martin Stenlo, Kristina Uvebrant, Deniz A. Bölükbas, Gabriel Hirdman, Ellen Broberg, Hooi Ching Lim, Snejana Hyllén, Evy Lundgren-Åkerlund, Leif Pierre, Franziska Olm, Sandra Lindstedt
التنسيق: مقال
اللغة:English
منشور في: BMC 2023-05-01
سلاسل:Respiratory Research
الموضوعات:
Acute respiratory distress syndrome
Integrin α10β1 mesenchymal stem cells
Lung disease
Advanced therapeutic medicinal products
الوصول للمادة أونلاين:https://doi.org/10.1186/s12931-023-02459-6

الانترنت

https://doi.org/10.1186/s12931-023-02459-6

مواد مشابهة